2 Patents
- US125595642026Compositions and Methods for Preventing or Reversing T-cell Exhaustion Through Ectonucleotidase Inhibition and Antibody-mediated Target Cytosis
Antagen Institute For Biomedical Research
0 cites - US120982122024Methods and Compositions for Promoting and Potentiating T-cell Mediated Immune Responses Through ADCC Targeting of CD39 Expressing Cells
Purinomia Biotech, Inc.
0 cites